TrialLeukemia2020

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation.

Rathana Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.